BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 20637651)

  • 1. Impaired hepatic removal of interleukin-6 in patients with liver cirrhosis.
    Wiest R; Weigert J; Wanninger J; Neumeier M; Bauer S; Schmidhofer S; Farkas S; Scherer MN; Schäffler A; Schölmerich J; Buechler C
    Cytokine; 2011 Feb; 53(2):178-83. PubMed ID: 20637651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic and hepatic vein galectin-3 are increased in patients with alcoholic liver cirrhosis and negatively correlate with liver function.
    Wanninger J; Weigert J; Wiest R; Bauer S; Karrasch T; Farkas S; Scherer MN; Walter R; Weiss TS; Hellerbrand C; Neumeier M; Schäffler A; Buechler C
    Cytokine; 2011 Sep; 55(3):435-40. PubMed ID: 21715185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated circulating adiponectin levels in liver cirrhosis are associated with reduced liver function and altered hepatic hemodynamics.
    Tietge UJ; Böker KH; Manns MP; Bahr MJ
    Am J Physiol Endocrinol Metab; 2004 Jul; 287(1):E82-9. PubMed ID: 15010338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Portal vein omentin is increased in patients with liver cirrhosis but is not associated with complications of portal hypertension.
    Eisinger K; Krautbauer S; Wiest R; Karrasch T; Hader Y; Scherer MN; Farkas S; Aslanidis C; Buechler C
    Eur J Clin Invest; 2013 Sep; 43(9):926-32. PubMed ID: 23855493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of quantitative portal venous, hepatic arterial, and total hepatic tissue blood flow using xenon CT in alcoholic liver cirrhosis-comparison with liver cirrhosis related to hepatitis C virus and nonalcoholic steatohepatitis.
    Takahashi H; Suzuki M; Ikeda H; Kobayashi M; Sase S; Yotsuyanagi H; Maeyama S; Iino S; Itoh F
    Alcohol Clin Exp Res; 2010 Feb; 34 Suppl 1():S7-S13. PubMed ID: 18986379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary sodium balance in patients with cirrhosis: relationship to quantitative parameters of liver function.
    Wensing G; Lotterer E; Link I; Hahn EG; Fleig WE
    Hepatology; 1997 Nov; 26(5):1149-55. PubMed ID: 9362355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced serum chemerin in patients with more severe liver cirrhosis.
    Eisinger K; Krautbauer S; Wiest R; Weiss TS; Buechler C
    Exp Mol Pathol; 2015 Apr; 98(2):208-13. PubMed ID: 25595667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute reactant cytokines and neutrophil adhesion after warm ischemia in cirrhotic and noncirrhotic human livers.
    Clavien PA; Camargo CA; Gorczynski R; Washington MK; Levy GA; Langer B; Greig PD
    Hepatology; 1996 Jun; 23(6):1456-63. PubMed ID: 8675164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum leptin levels in patients with nonalcoholic chronic liver disease.
    Nakamuta M; Tada S; Uchimura K; Enjoji M; Kinukawa N; Iwamoto H; Sugimoto R; Shimada M; Ohashi M; Sugimachi K; Nawata H
    Hepatogastroenterology; 2001; 48(38):527-32. PubMed ID: 11379347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-6, nitric oxide, and the clinical and hemodynamic alterations of patients with liver cirrhosis.
    Genesca J; Gonzalez A; Segura R; Catalan R; Marti R; Varela E; Cadelina G; Martinez M; Lopez-Talavera JC; Esteban R; Groszmann RJ; Guardia J
    Am J Gastroenterol; 1999 Jan; 94(1):169-77. PubMed ID: 9934750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Measurement of hepatic venous pressure gradient in liver cirrhosis: relationship with the status of cirrhosis, varices, and ascites in Korea].
    Kim MY; Baik SK; Suk KT; Yea CJ; Lee IY; Kim JW; Cha SH; Kim YJ; Um SH; Han KH
    Korean J Hepatol; 2008 Jun; 14(2):150-8. PubMed ID: 18617762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Serum concentration of bile acids and portal hypertension in cirrhotic patients. Possible correlations].
    Tarantino G; Cambri S; Ferrara A; Marzano M; Liberti A; Vellone G; Ciccarelli AF
    Riv Eur Sci Med Farmacol; 1989 Jun; 11(3):195-205. PubMed ID: 2640042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic function and portal hemodynamics in patients with liver cirrhosis.
    Kawasaki T; Moriyasu F; Kimura T; Someda H; Tamada T; Yamashita Y; Ono S; Kajimura K; Hamato N; Okuma M
    Am J Gastroenterol; 1990 Sep; 85(9):1160-4. PubMed ID: 2202201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma substance P levels in patients with liver cirrhosis: relationship to systemic and portal hemodynamics.
    Lee FY; Lin HC; Tsai YT; Chang FY; Lu RH; Hou MC; Li CP; Chu CJ; Wang SS; Lee SD
    Am J Gastroenterol; 1997 Nov; 92(11):2080-4. PubMed ID: 9362197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Connective tissue growth factor level is increased in patients with liver cirrhosis but is not associated with complications or extent of liver injury.
    Bauer S; Eisinger K; Wiest R; Karrasch T; Scherer MN; Farkas S; Aslanidis C; Buechler C
    Regul Pept; 2012 Nov; 179(1-3):10-4. PubMed ID: 22960408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-6 in hepatitis C cirrhosis.
    Malaguarnera M; Trovato BA; Laurino A; Di Fazio I; Romeo MA; Motta M
    Panminerva Med; 1996 Dec; 38(4):207-10. PubMed ID: 9063027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma endotoxin and serum cytokine levels in patients with alcoholic hepatitis: relation to severity of liver disturbance.
    Fujimoto M; Uemura M; Nakatani Y; Tsujita S; Hoppo K; Tamagawa T; Kitano H; Kikukawa M; Ann T; Ishii Y; Kojima H; Sakurai S; Tanaka R; Namisaki T; Noguchi R; Higashino T; Kikuchi E; Nishimura K; Takaya A; Fukui H
    Alcohol Clin Exp Res; 2000 Apr; 24(4 Suppl):48S-54S. PubMed ID: 10803780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-6 and IL-18 in blood may discriminate cirrhotic patients with and without minimal hepatic encephalopathy.
    Montoliu C; Piedrafita B; Serra MA; del Olmo JA; Urios A; Rodrigo JM; Felipo V
    J Clin Gastroenterol; 2009 Mar; 43(3):272-9. PubMed ID: 18562979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic tissue endothelin-1 levels in chronic liver disease correlate with disease severity and ascites.
    Alam I; Bass NM; Bacchetti P; Gee L; Rockey DC
    Am J Gastroenterol; 2000 Jan; 95(1):199-203. PubMed ID: 10638583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Endogenous digitalis-like factor in liver cirrhosis and cholestasis].
    Behrens R; Glauck D; Kaltenborn G; Behrens B; Wache H; Schlee H; Rink C; Böhme I; Nilius R
    Z Gastroenterol; 1993 Feb; 31 Suppl 2():20-3. PubMed ID: 7483706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.